OA
Orbimed Advisors LLC disclosed a 14% stake in ADRX
Orbimed Advisors LLC reported owning 14% of ADARx Pharmaceuticals, Inc. (ADRX) (14,913,764 shares) in a Schedule 13D filed Oct 2, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Oct 2, 2026
- Source
- Schedule 13D